CompletedNot Applicable

Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS

Italy16 participantsStarted 2013-06-30

Plain-language summary

The purpose of this study is to prove that luteal phase supplementation with recombinant LH can solve the luteal phase deficiency after Gnrh agonist oocytes triggering in women at risk of OHSS

Who can participate

Age range18 Years – 43 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients with an oestradiol \> 4000 pg/ml on the oocytes triggering day * patient with more than 24 follicles of diameter greater than 12 mm on the oocytes triggering day Exclusion Criteria: * patients with no risk of OHSS on the oocytes triggering day * patients with an oestradiol \< 4000 pg/ml on the oocytes triggering day * patient with less than 24 follicles of diameter greater than 12 mm on the oocytes triggering day

What they're measuring

Pregnancy Rate and Implantation Rate

Timeframe: From 14 days after the pick up to six weeks of gestation

Trial details

NCT IDNCT02200952

SponsorSan Carlo Public Hospital, Potenza, Italy

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2014-06-30

View on ClinicalTrials.gov More Ovarian Hyperstimulation Syndrome trials